Skip to Content

Zhejiang Guobang Pharmaceuticals, China, 2025

GMP Audit Report

Company
Zhejiang Guobang Pharmaceuticals

Product(s)
Marbofloxacin

Country
China

Audit Year
2025

0.00 € 0.00 €
0.00 €